Fenharmane

Fenharmane
Clinical data
Other namesFenharman; Phenharman; Phenharmane; Fenoharman; Fenoharmane; Phenoharman; Phenoharmane; 1-Benzyl-1,2,3,4-tetrahydronorharmane; Benzyltetrahydronorharman
Drug classSedative; Tranquilizer; Reserpine-like agent
Identifiers
  • 1-benzyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H18N2
Molar mass262.356 g·mol−1
3D model (JSmol)
  • C1CNC(C2=C1C3=CC=CC=C3N2)CC4=CC=CC=C4
  • InChI=1S/C18H18N2/c1-2-6-13(7-3-1)12-17-18-15(10-11-19-17)14-8-4-5-9-16(14)20-18/h1-9,17,19-20H,10-12H2
  • Key:LHVNPTMRAQQPID-UHFFFAOYSA-N

Fenharmane (INNTooltip International Nonproprietary Name), also known as 1-benzyl-1,2,3,4-tetrahydronorharmane, is a sedative and tranquilizer of the β-carboline family.[1][2] It has been said to have actions similar to those of reserpine, a monoamine-depleting agent.[3][4][5][6] The drug has been reported to induce symptoms of depression analogously to reserpine.[7][8] Fenharmane was developed in Czechoslovakia in the late 1950s.[3][2][9]

See also

[edit]

References

[edit]
  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 144–145. ISBN 978-1-4757-2085-3.
  2. ^ a b Švestka J (2000). "S31.03 The history of czech psychopharmacology and psychopharmacotherapy of affective and schizophrenic disorders" (PDF). European Psychiatry. 15 (S2): 277s. doi:10.1016/S0924-9338(00)94205-6. ISSN 0924-9338. Retrieved 30 May 2025.
  3. ^ a b Dlabac A, Macek K, Vanecek M, Trcka V (April 1959). "Reserpinový úćinek fenoharmanu" [Reserpine-like action of phenoharmane]. Ceskoslovenska Fysiologie (in Czech). 8 (3): 177–178. PMID 13671512.
  4. ^ Trcka V, Dlabac A, Vanecek M (1961). "[The reserpine-like action of 1-benzyl-1,2,3,4-tetrahydronorharmane (fenoharman)]". Journal de Physiologie (in French). 53: 488–489. PMID 13777950.
  5. ^ Nahunek K, Rodova A, Hosak L, Jaros M, Hadlik J (July 1962). "[Nialamid and its combinations with reserpine-like substances (fenoharman, reserpine) in the therapy of endogenous depressions]". Deutsches Medizinisches Journal (in German). 13: 424–425. PMID 14477998.
  6. ^ Rysanek K, Vitek V, Spankova H (1962). "[Comparative effects of Reserpine and Fenoharman on the absorption and liberation of serotonin in vivo and in vitro]". Activitas Nervosa Superior (in Czech). 4: 220–221. PMID 14495652.
  7. ^ Bermanzohn PC, Siris SG (1992). "Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia". Comprehensive Psychiatry. 33 (4): 221–232. doi:10.1016/0010-440x(92)90045-r. PMID 1353715.
  8. ^ Tesařová O (1972). "Experimental Depression Caused by Apomorphine and Phenoharmane". Pharmacopsychiatry. 5 (1): 13–19. doi:10.1055/s-0028-1094329. ISSN 0176-3679. Retrieved 30 May 2025.
  9. ^ Vinar O (November 1960). "[Use of Fenoharman, a new Czechoslovakian preparation, in psychiatry (preliminary communication)]". Casopis Lekaru Ceskych (in Czech). 99: 1422–1424. PMID 13781443.



Stub icon

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fenharmane&oldid=1293369631"